Dimensional Fund Advisors
CELL

Dimensional Fund Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Dimensional Fund Advisors’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,591
Closed -$25.5K – 3508
2023
Q3 		$25.5K Hold
25,591
– – ﹤0.01% 3429
2023
Q2 		$12.5K Sell
25,591
-42,020
-62% -$34.4K ﹤0.01% 3465
2023
Q1 		$78.4K Sell
67,611
-8,143
-11% -$14.9K ﹤0.01% 3339
2022
Q4 		$203 Sell
75,754
-88,972
-54% -$235K ﹤0.01% 3224
2022
Q3 		$471K Buy
164,726
+67,833
+70% +$288K ﹤0.01% 3058
2022
Q2 		$481K Buy
+96,893
New +$508K ﹤0.01% 3073
2021
Q3 		– Sell
-4,952
Closed -$222K – 3546
2021
Q2 		$222K Hold
4,952
– – ﹤0.01% 3322
2021
Q1 		$249K Buy
+4,952
New +$338K ﹤0.01% 3253

Dimensional Fund Advisors's CELL Position: Q4 2023 in Review

Dimensional Fund Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 25,591 shares — an estimated $25.5K sold.

Dimensional Fund Advisors first reported a position in CELL in Q1 2021 and held it in 8 quarters. The position peaked at $481K in Q2 2022. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Dimensional Fund Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 25,591 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $25.5K.
  • Dimensional Fund Advisors first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Dimensional Fund Advisors's PhenomeX Inc. Common Stock position peaked at $481K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.